Featured Research

from universities, journals, and other organizations

Virus protects against lupus

Date:
April 2, 2012
Source:
National Jewish Health
Summary:
To the surprise of investigating researchers, an animal model of Epstein Barr virus protected lupus-prone mice against development of the autoimmune disease. Earlier work had suggested that EBV might promote the development of autoimmunity.

To the surprise of investigating researchers, an animal model of Epstein Barr virus protected lupus-prone mice against development of the autoimmune disease. Earlier work had suggested that EBV might promote the development of autoimmunity.

"We were completely surprised. So, we redid the experiments, and the results came out the same," said Dr. Pelanda, lead author on the paper appearing online in Proceedings of the National Academy of Sciences. "We believe these findings could lead to therapeutic targets for lupus and other autoimmune diseases."

Epstein Barr virus (EBV) infects most people in the United States by the time they are adults. It causes mononucleosis in about 35 to 50 percent of those infected. Acute symptoms usually pass within weeks, after which the virus goes into a dormant state within the body. The infection persists for a person's entire life and can activate in some cases.

Although the virus infects the vast majority of adults, it is found in an even higher percentage of lupus patients, leading to the hypothesis that it may predispose people to autoimmune diseases.

EBV does not infect mice, but a related virus, gammahervesvirus 68, does and has a similar pattern of infection and symptoms. So Dr. Pelanda and her colleagues infected a mouse model of lupus with the virus. One hundred percent of the lupus model mice develop lupus by about one year of age.

In those mice infected with the gammaherpesvirus 68, however, antibodies associated with lupus did not increase, and actually decreased significantly in female mice. In kidneys, a major site of tissue damage in lupus, viral infection reduced tissue damage from 80 percent to 20 percent. Other measures of lupus, including activation of lymphocytes and dendritic cells, were also reduced in lupus-prone mice infected with the gammaherpesvirus 68.

"The virus inhibits the development and progression of lupus on many levels, from cellular to humoral and organ," said Dr. Pelanda. "For that reason, we believe it is affecting a basic mechanisms of autoimmunity."

The researchers do not know how the gammaherpesvirus inhibits lupus, but have begun a systematic series of experiments to evaluate several potential mechanisms.


Story Source:

The above story is based on materials provided by National Jewish Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jennifer D. Larson, Joshua M. Thurman, Anatoly V. Rubtsov, David Claypool, Philippa Marrack, Linda F. van Dyk, Raul M. Torres, and Roberta Pelanda. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. PNAS, 2012 DOI: 10.1073/pnas.1203019109

Cite This Page:

National Jewish Health. "Virus protects against lupus." ScienceDaily. ScienceDaily, 2 April 2012. <www.sciencedaily.com/releases/2012/04/120402162555.htm>.
National Jewish Health. (2012, April 2). Virus protects against lupus. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2012/04/120402162555.htm
National Jewish Health. "Virus protects against lupus." ScienceDaily. www.sciencedaily.com/releases/2012/04/120402162555.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins